300942 易瑞生物
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资84,481-16.10%100,690145,179195,75821,944
投资性房地产0--0005,250
固定资产570,43557.10%363,11157,10283,98652,628
在建工程6,806-96.59%199,793356,626190,86751,341
无形资产37,787-3.71%39,24341,39342,40042,600
商誉0--0000
其他非流动资产6,678146.15%2,71318,37095,02681,113
706,1860.09%705,550618,669608,036254,876

流动资产
货币资金449,80453.31%293,399481,749247,451342,211
应收账款99,7306.03%94,05976,14883,87897,052
存货57,91043.24%40,43031,461100,60893,859
其他流动资产167,929-48.13%323,728148,312242,482364,522
775,3743.16%751,616737,670674,419897,644

流动负债
短期借款0--0000
应付票据0--0000
应付帐款74,83827.36%58,76277,35265,10755,658
其他流动负债75,467-19.02%93,19559,575134,676100,968
150,304-1.09%151,958136,927199,784156,626
流动资产净值625,0694.24%599,658600,743474,636741,018
资产总额减流动负债1,331,2562.00%1,305,2081,219,4121,082,672995,894

非流动负债
长期借款160,534-1.64%163,218100,32956,3200
应付债券251,960-4.26%263,169245,45200
其他非流动负债8,410-1.97%8,57924,90361,65149,314
420,904-3.23%434,966370,684117,97149,314

总权益
    实收股本405,0690.93%401,317400,860400,860400,860
    储备项目503,0227.55%467,689448,134564,031543,903
股东权益908,0904.50%869,005848,994964,891944,763
非控股权益2,26182.78%1,237(266)(190)1,817